Fig. 2From: Salvage use of tissue plasminogen activator (tPA) in the setting of acute respiratory distress syndrome (ARDS) due to COVID-19 in the USA: a Markov decision analysisState transition diagram, salvage use tPA, and no tPA for patients with PF< 60 (a, b)Back to article page